Literature DB >> 20950691

Formalin fixation affects equilibrium partitioning of an ionic contrast agent-microcomputed tomography (EPIC-μCT) imaging of osteochondral samples.

K E M Benders1, J Malda, D B F Saris, W J A Dhert, R Steck, D W Hutmacher, T J Klein.   

Abstract

OBJECTIVE: Equilibrium Partitioning of an Ionic Contrast agent with microcomputed tomography (EPIC-μCT) is a non-invasive technique to quantify and visualize the three-dimensional distribution of glycosaminoglycans (GAGs) in fresh cartilage tissue. However, it is unclear whether this technique is applicable to already fixed tissues. Therefore, this study aimed at investigating whether formalin fixation of bovine cartilage affects X-ray attenuation, and thus the interpretation of EPIC-μCT data.
DESIGN: Osteochondral samples (n=24) were incubated with ioxaglate, an ionic contrast agent, for 22h prior to μCT scanning. The samples were scanned in both formalin-fixed and fresh conditions. GAG content was measured using a biochemical assay and normalized to wet weight, dry weight, and water content to determine potential reasons for differences in X-ray attenuation.
RESULTS: The expected zonal distribution of contrast agent/GAGs was observed for both fixed and fresh cartilage specimens. However, despite no significant differences in GAG concentrations or physical properties between fixed and fresh samples, the average attenuation levels of formalin-fixed cartilage were 14.3% lower than in fresh samples.
CONCLUSIONS: EPIC-μCT is useful for three-dimensional visualization of GAGs in formalin-fixed cartilage. However, a significant reduction in X-ray attenuation for fixed (compared to fresh) cartilage must be taken into account and adjusted for accordingly when quantifying GAG concentrations using EPIC-μCT.
Copyright © 2010 Osteoarthritis Research Society International. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20950691     DOI: 10.1016/j.joca.2010.10.005

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  7 in total

1.  The use of nano-computed tomography to enhance musculoskeletal research.

Authors:  Basma M Khoury; Erin M R Bigelow; Lauren M Smith; Stephen H Schlecht; Erica L Scheller; Nelly Andarawis-Puri; Karl J Jepsen
Journal:  Connect Tissue Res       Date:  2015-02-03       Impact factor: 3.417

2.  Quantitative imaging of excised osteoarthritic cartilage using spectral CT.

Authors:  Kishore Rajendran; Caroline Löbker; Benjamin S Schon; Christopher J Bateman; Raja Aamir Younis; Niels J A de Ruiter; Alex I Chernoglazov; Mohsen Ramyar; Gary J Hooper; Anthony P H Butler; Tim B F Woodfield; Nigel G Anderson
Journal:  Eur Radiol       Date:  2016-05-10       Impact factor: 5.315

3.  Contrast-enhanced microCT (EPIC-μCT) ex vivo applied to the mouse and human jaw joint.

Authors:  G A P Renders; L Mulder; A S Lin; G E J Langenbach; J H Koolstra; R E Guldberg; V Everts
Journal:  Dentomaxillofac Radiol       Date:  2013-12-18       Impact factor: 2.419

4.  Initial application of EPIC-μCT to assess mouse articular cartilage morphology and composition: effects of aging and treadmill running.

Authors:  N Kotwal; J Li; J Sandy; A Plaas; D R Sumner
Journal:  Osteoarthritis Cartilage       Date:  2012-05-15       Impact factor: 6.576

5.  Murine articular cartilage morphology and compositional quantification with high resolution cationic contrast-enhanced μCT.

Authors:  Maleeha Mashiatulla; Meghan M Moran; Deva Chan; Jun Li; Jonathan D Freedman; Brian D Snyder; Mark W Grinstaff; Anna Plaas; Dale R Sumner
Journal:  J Orthop Res       Date:  2017-05-23       Impact factor: 3.494

6.  Multiphasic construct studied in an ectopic osteochondral defect model.

Authors:  June E Jeon; Cédryck Vaquette; Christina Theodoropoulos; Travis J Klein; Dietmar W Hutmacher
Journal:  J R Soc Interface       Date:  2014-04-02       Impact factor: 4.118

7.  Hyaluronic acid enhances the mechanical properties of tissue-engineered cartilage constructs.

Authors:  Peter A Levett; Dietmar W Hutmacher; Jos Malda; Travis J Klein
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.